Peer-influenced content. Sources you trust. No registration required. This is HCN.

Mount SinaiUsing the Body’s Own Immune System and On and Off Switches to Vaccinate Patients Against their Cancer

A look into the results of a few patients that took part in a phase 1/2 trial at the Icahn School of Medicine at Mount Sinai in New York City: a woman who had breast cancer for 23 years and gone through 12 lines of therapy and a man with non-Hodgkin lymphoma (NHL) since 2017. Both showed complete response to the novel vaccine.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form